Apoptosis in multiple myeloma: therapeutic implications

D Chauhan1, K C Anderson

  • 1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

Insights

This review explores apoptosis and survival pathways in Multiple Myeloma (MM), a fatal blood cancer. Understanding these pathways reveals new therapeutic targets for MM treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Cell Biology

Background:

  • Apoptosis is crucial for cancer therapy effectiveness.
  • Multiple Myeloma (MM) is a fatal hematological malignancy with limited treatment options.
  • Dysregulation of apoptotic pathways is implicated in cancer development and progression.

Purpose of the Study:

  • To review the current understanding of apoptotic and survival signaling pathways in Multiple Myeloma cells.
  • To identify novel apoptotic and anti-apoptotic proteins involved in MM pathogenesis.
  • To highlight potential therapeutic targets for novel MM treatments.

Main Methods:

  • Literature review of studies on apoptosis and survival signaling in MM.
  • Analysis of identified apoptotic and anti-apoptotic proteins in MM.
  • Evaluation of therapeutic strategies targeting these pathways.

Main Results:

  • Abnormalities in apoptotic pathways are linked to MM pathogenesis.
  • Novel apoptotic and anti-apoptotic proteins have been identified in MM cells.
  • These proteins represent potential targets for new MM therapies.

Conclusions:

  • Targeting apoptotic and survival pathways offers a promising strategy for MM treatment.
  • Further research into these pathways could lead to more effective therapies for Multiple Myeloma.
  • Understanding MM cell signaling is key to overcoming treatment resistance.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...